SHPAX vs. FHCCX
Compare and contrast key facts about Saratoga Health & Biotechnology Fund (SHPAX) and Fidelity Advisor Health Care Fund Class C (FHCCX).
SHPAX is managed by Saratoga. It was launched on Jul 14, 1999. FHCCX is managed by Fidelity. It was launched on Nov 3, 1997.
Performance
SHPAX vs. FHCCX - Performance Comparison
Loading graphics...
SHPAX vs. FHCCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | -1.13% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
FHCCX Fidelity Advisor Health Care Fund Class C | -9.80% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | 6.37% | 23.12% |
Returns By Period
In the year-to-date period, SHPAX achieves a -1.13% return, which is significantly higher than FHCCX's -9.80% return. Over the past 10 years, SHPAX has outperformed FHCCX with an annualized return of 6.84%, while FHCCX has yielded a comparatively lower 5.57% annualized return.
SHPAX
- 1D
- 0.96%
- 1M
- -6.99%
- YTD
- -1.13%
- 6M
- 10.24%
- 1Y
- 12.17%
- 3Y*
- 6.93%
- 5Y*
- 5.73%
- 10Y*
- 6.84%
FHCCX
- 1D
- -0.72%
- 1M
- -9.58%
- YTD
- -9.80%
- 6M
- -16.82%
- 1Y
- -13.69%
- 3Y*
- -3.33%
- 5Y*
- -3.13%
- 10Y*
- 5.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SHPAX vs. FHCCX - Expense Ratio Comparison
SHPAX has a 2.90% expense ratio, which is higher than FHCCX's 1.72% expense ratio.
Return for Risk
SHPAX vs. FHCCX — Risk / Return Rank
SHPAX
FHCCX
SHPAX vs. FHCCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Health & Biotechnology Fund (SHPAX) and Fidelity Advisor Health Care Fund Class C (FHCCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SHPAX | FHCCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.78 | -0.56 | +1.34 |
Sortino ratioReturn per unit of downside risk | 1.18 | -0.55 | +1.72 |
Omega ratioGain probability vs. loss probability | 1.15 | 0.90 | +0.24 |
Calmar ratioReturn relative to maximum drawdown | 1.56 | -0.55 | +2.11 |
Martin ratioReturn relative to average drawdown | 4.30 | -1.35 | +5.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SHPAX | FHCCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.78 | -0.56 | +1.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.41 | -0.16 | +0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.29 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.45 | -0.15 |
Correlation
The correlation between SHPAX and FHCCX is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
SHPAX vs. FHCCX - Dividend Comparison
SHPAX's dividend yield for the trailing twelve months is around 3.70%, while FHCCX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 3.70% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
Drawdowns
SHPAX vs. FHCCX - Drawdown Comparison
The maximum SHPAX drawdown since its inception was -69.50%, which is greater than FHCCX's maximum drawdown of -45.28%. Use the drawdown chart below to compare losses from any high point for SHPAX and FHCCX.
Loading graphics...
Drawdown Indicators
| SHPAX | FHCCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.50% | -45.28% | -24.22% |
Max Drawdown (1Y)Largest decline over 1 year | -7.87% | -27.25% | +19.38% |
Max Drawdown (5Y)Largest decline over 5 years | -16.32% | -29.67% | +13.35% |
Max Drawdown (10Y)Largest decline over 10 years | -28.05% | -29.67% | +1.62% |
Current DrawdownCurrent decline from peak | -6.99% | -27.25% | +20.26% |
Average DrawdownAverage peak-to-trough decline | -28.07% | -10.12% | -17.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.86% | 11.08% | -8.22% |
Volatility
SHPAX vs. FHCCX - Volatility Comparison
The current volatility for Saratoga Health & Biotechnology Fund (SHPAX) is 4.62%, while Fidelity Advisor Health Care Fund Class C (FHCCX) has a volatility of 5.59%. This indicates that SHPAX experiences smaller price fluctuations and is considered to be less risky than FHCCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SHPAX | FHCCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.62% | 5.59% | -0.97% |
Volatility (6M)Calculated over the trailing 6-month period | 9.76% | 22.17% | -12.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.57% | 25.40% | -8.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.19% | 19.34% | -5.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.57% | 19.55% | -2.98% |